Schedule 13G ownership disclosure
UROGEN PHARMA LTD
Security class unavailable · CUSIP: M96088105
Event date: 2022-11-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,196,908
- Percent of class
- 5.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-22-000637
- Form type
- SC 13G
- Filer
- Stonepine Capital Management, LLC
- CIK
- CIK 1440771
- Filed
- Dec 01, 2022
- Reporting period
- Nov 22, 2022
- Description
- Schedule 13G beneficial ownership